Emergent BioSolutions (EBS) Selling, General & Administrative (2011 - 2026)
Emergent BioSolutions (EBS) Selling, General & Administrative (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 304.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 588.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 5.21 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 184.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 928.80 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 318.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 381.00 Mn |
| 10 | Emergent BioSolutions | 389.77 Mn | 228.27 Mn | 84.10 Mn | 46.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.60 Mn |
| Dec 31, 2025 | 51.10 Mn |
| Sep 30, 2025 | 38.90 Mn |
| Jun 30, 2025 | 43.70 Mn |
| Mar 31, 2025 | 52.40 Mn |
| Dec 31, 2024 | 60.80 Mn |
| Sep 30, 2024 | 76.60 Mn |
| Jun 30, 2024 | 85.90 Mn |
| Mar 31, 2024 | 84.70 Mn |
| Dec 31, 2023 | 89.70 Mn |
| Sep 30, 2023 | 86.00 Mn |
| Jun 30, 2023 | 91.40 Mn |
| Mar 31, 2023 | 101.30 Mn |
| Dec 31, 2022 | 93.40 Mn |
| Sep 30, 2022 | 81.80 Mn |
| Jun 30, 2022 | 81.10 Mn |
| Mar 31, 2022 | 84.80 Mn |
| Dec 31, 2021 | 94.50 Mn |
| Sep 30, 2021 | 82.10 Mn |
| Jun 30, 2021 | 91.20 Mn |